May 6, 2026
Eli Lilly
Lebanon-IN
Investment across two of the company’s three sites in Lebanon, Indiana.
The investment will incorporate new process designs and technologies at one of the company's future active pharmaceutical ingredient sites as well as at its first dedicated genetic medicine manufacturing facility.
Part of a larger, previously announced $23 billion company investment.
Disease Area:
Drug Type:
April 30, 2026
Novartis
Morrisville-NC
Finalized plans to build a manufacturing facility focused on active pharmaceutical ingredients(API) for solid dosage tablets, capsules and RNA therapeutics. The 56,200-square-foot site will expand the company’s presence in North Carolina to five facilities.
Plans were initially announced in November 2025.
Part of a larger, previously announced $23 billion company investment.
Disease Area:
Drug Type:
April 22, 2026
AbbVie
Durham-NC
A 185-acre campus that will integrate advanced manufacturing and laboratory technologies with AI to support the production of the company’s immunology, neuroscience and oncology medicines.
The project will create about 734 jobs in engineering, manufacturing operations and other technical roles and will generate more than 2,000 construction jobs during campus development.
Part of a larger, previously announced $100 billion company investment.
Disease Area:
Drug Type:
March 9, 2026
CSL
Kankakee-IL
An expansion of a manufacturing facility that will increase production of life-sustaining, plasma-derived therapies for people living with rare and serious diseases and other acute medical issues. The development will add at least 300 jobs.
Added details made public for an original November 2025 announcement.
Disease Area:
Drug Type:
February 23, 2026
AbbVie
North Chicago-IL
Two new active pharmaceutical ingredient (API) manufacturing facilities that will integrate advanced manufacturing technologies with artificial intelligence to support the production of next-generation neuroscience and obesity medications. To support these new facilities, AbbVie will hire 300 people in North Chicago, including engineers, scientists, manufacturing operators and lab technicians.
Part of a larger, previously announced $100 billion company investment.
Disease Area:
Drug Type:
No entries found matching your criteria. Please modify your filters.